Skip to main content
Log in

Extremely late (7 years) paclitaxel-eluting stent thrombosis

  • Case Report
  • Published:
Cardiovascular Intervention and Therapeutics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

References

  1. Serruys PW, Kutryk MJ, Ong AT. Coronary-artery stents. N Engl J Med. 2006;354(5):483–95.

    Article  CAS  PubMed  Google Scholar 

  2. Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, et al. Clinical end points in coronary stent trials: a case for standardized definitions. Acad Res Consort Circulation. 2007;115(17):2344–51.

    Google Scholar 

  3. Otsuka F, Nakano M, Ladich E, Kolodgie FD, Virmani R. Pathologic etiologies of late and very late stent thrombosis following first-generation drug-eluting stent placement. Thrombosis. 2012;2012:608593.

    Article  PubMed Central  PubMed  Google Scholar 

  4. Cook S, Wenaweser P, Togni M, Billinger M, Morger C, Seiler C, et al. Incomplete stent apposition and very late stent thrombosis after drug-eluting stent implantation. Circulation. 2007;115(18):2426–34.

    Article  CAS  PubMed  Google Scholar 

  5. De la Torre Hernández JM, Alfonso F, Gimeno F, Diarte JA, Lopez-Palop R, de Pérez Prado A, et al. Thrombosis of second-generation drug-eluting stents in real practice results from the multicenter Spanish registry ESTROFA-2. JACC Cardiovasc Interv. 2010;3(9):909–11.

    Google Scholar 

  6. Schinkel AF, Barlis P, van Beusekom HM, Serruys PW, Regar E. Optical coherence tomography findings in very late (4 years) paclitaxel-eluting stent thrombosis. JACC Cardiovasc Interv. 2008;1(4):449–51.

    Article  PubMed  Google Scholar 

  7. Joyal D, Rudski L. Sirolimus-eluting stent thrombosis several years after clopidogrel discontinuation. J Invasive Cardiol. 2007;19(9):E265–7.

    PubMed  Google Scholar 

  8. Kimura T, Morimoto T, Nakagawa Y, Kawai K, Miyakazi S, Muramatsu T, et al. Very late stent thrombosis and late target lesion revascularization after sirolimus-eluting stent implantation: five-year outcome of the j-Cypher registry. Circulation. 2012;125(4):584–91.

    Article  CAS  PubMed  Google Scholar 

  9. Taylor-Sutton JE, Kim MC. Very late stent thrombosis approximately 7 years after deployment and one-week cessation of dual antiplatelet therapy. J Invasive Cardiol. 2011;23(12):E273–6.

    PubMed  Google Scholar 

  10. Spagnoli V, Veugeois A, Caussin C, Amabile N. Extremely late drug-eluting stent thrombosis related to uncovered struts: the phantom menace. Eur Heart J. 2013;34(31):2428.

    Article  PubMed  Google Scholar 

  11. Siddiqi OK, Faxon DP. Very late stent thrombosis: current concepts. Curr Opin Cardiol. 2012;27(6):634–41.

    Article  PubMed  Google Scholar 

  12. Kuchulakanti PK, Chu WW, Torguson R, Ohlmann P, Rha SW, Clavijo LC, et al. Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents. Circulation. 2006;113(8):1108–13.

    Article  CAS  PubMed  Google Scholar 

  13. Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM, Stankovic G, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA. 2005;293(17):2126–30.

    Article  CAS  PubMed  Google Scholar 

  14. Lee CW, Kang SJ, Park DW, Lee SH, Kim YH, Kim JJ, et al. Intravascular ultrasound findings in patients with very late stent thrombosis after either drug-eluting or bare-metal stent implantation. J Am Coll Cardiol. 2010;55(18):1936–42.

    Article  PubMed  Google Scholar 

  15. Costa MA, Sabate M, Angiolillo DJ, Jimenez-Quevedo P, Teirstein P, Carter A, et al. Intravascular ultrasound characterization of the “black hole” phenomenon after drug-eluting stent implantation. Am J Cardiol. 2006;97(2):203–6.

    Article  CAS  PubMed  Google Scholar 

  16. Zhang T, Shen L, Hu L, He B. Optimal duration of dual-antiplatelet therapy following drug-eluting stent implantation: a meta-analysis. J Clin Pharmacol. 2013;53(3):345–51.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J. A. Linares Vicente.

Electronic supplementary material

Below is the link to the electronic supplementary material.

12928_2014_270_MOESM1_ESM.avi

Video 1: initial left anterior descending artery angiography, showing thrombotic content at proximal edge and middle stent segment (AVI 1371 kb)

12928_2014_270_MOESM2_ESM.avi

Video 2: final angiographic result at left anterior descending artery after percutaneous coronary intervention (AVI 1660 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Linares Vicente, J.A., Ruiz Arroyo, J.R., Simó Sánchez, B. et al. Extremely late (7 years) paclitaxel-eluting stent thrombosis. Cardiovasc Interv and Ther 30, 176–178 (2015). https://doi.org/10.1007/s12928-014-0270-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12928-014-0270-8

Keywords

Navigation